Project: dissection
2611 significantly associated models · 435 unique genes
# | chr | p0 | p1 | # assoc genes | # joint models | best TWAS P | best SNP P | cond SNP P | % var exp | joint genes |
---|---|---|---|---|---|---|---|---|---|---|
1 | 1 | 120674658 | 122571615 | 3 | 1 | 1.8e-08 | 1.4e-07 | 3.3e-01 | 97 | Fam169b |
2 | 1 | 203698095 | 205092962 | 1 | 1 | 1.6e-07 | 7.5e-07 | 3.8e-02 | 83 | Otub1 |
3 | 1 | 251447555 | 253100945 | 3 | 1 | 3.8e-08 | 2.8e-08 | 5.2e-02 | 88 | Add3 |
4 | 1 | 253445764 | 260518987 | 41 | 7 | 4.1e-40 | 4.1e-41 | NaN | NaN | Gpam Habp2 Eno4 Sfxn4 Tcf7l2 NA NA |
5 | 2 | 43366934 | 44763574 | 1 | 1 | 1.4e-07 | 9.9e-08 | 1.0e-03 | 62 | Il6st |
6 | 2 | 117887529 | 120258488 | 8 | 1 | 3.7e-08 | 3.1e-08 | 1.0e+00 | 100 | Qrfpr |
7 | 2 | 123236866 | 125075599 | 4 | 1 | 4.6e-10 | 1.2e-06 | 3.0e-03 | 63 | Jade1 |
8 | 2 | 226367830 | 227766193 | 1 | 1 | 2.1e-07 | 1.4e-08 | 2.2e-02 | 84 | Eif4e |
9 | 3 | 106069409 | 108252074 | 8 | 1 | 6.0e-08 | 1.3e-07 | 1.0e+00 | 100 | Ehd4 |
10 | 3 | 114188900 | 117826996 | 27 | 1 | 3.3e-08 | 3.0e-08 | 1.0e+00 | 100 | Ubox5 |
11 | 3 | 126160536 | 128707024 | 7 | 3 | 3.3e-12 | 2.2e-12 | 1.0e+00 | 100 | Sptlc3 Ndufaf5 AABR07054000.1 |
12 | 3 | 129554891 | 132898674 | 17 | 9 | 9.6e-19 | 1.4e-17 | 1.0e+00 | 100 | Kif16b Pcsk2 Dstn Kat14 Rbbp9 Sec23b Otor Smim26 NA |
13 | 5 | 47710012 | 49968409 | 6 | 2 | 6.7e-09 | 2.6e-09 | 1.0e+00 | 100 | Cfap206 RGD1359108 |
14 | 5 | 147778855 | 149174573 | 1 | 1 | 1.5e-07 | 8.0e-08 | 1.0e+00 | 100 | Tcea3 |
15 | 6 | 96850756 | 98633235 | 4 | 1 | 1.5e-08 | 2.3e-08 | 2.0e-01 | 95 | Pigh |
16 | 6 | 100080023 | 100868818 | 1 | 1 | 2.3e-07 | 4.4e-07 | 1.0e+00 | 100 | Galnt16 |
17 | 7 | 24880148 | 26365256 | 3 | 1 | 8.7e-08 | 5.1e-08 | 1.0e+00 | 100 | Ikbip |
18 | 7 | 26902995 | 30734621 | 20 | 6 | 3.0e-20 | 5.7e-25 | NaN | NaN | Cdk17 Elk3 Tmcc3 Cradd Socs2 Mir331 |
19 | 7 | 81442141 | 85355253 | 4 | 1 | 5.4e-10 | 8.9e-12 | 2.7e-05 | 62 | Med30 |
20 | 7 | 127692699 | 132411050 | 45 | 6 | 1.3e-09 | 2.7e-09 | 1.0e+00 | 100 | Zfp641 Tuba1b Hdac7 Ddx23 Kansl2 NA |
21 | 8 | 75290117 | 76689055 | 1 | 1 | 2.9e-07 | 7.5e-08 | 1.2e-63 | -881 | Myo5c |
22 | 8 | 89750909 | 91141602 | 1 | 1 | 1.6e-07 | 7.0e-06 | 8.6e-01 | 100 | Rasgrf1 |
23 | 8 | 95494368 | 98183778 | 7 | 2 | 5.5e-10 | 1.7e-08 | 1.6e-119 | -1598 | Atp1b3 Zbtb38 |
24 | 8 | 108584253 | 112100485 | 41 | 6 | 7.8e-10 | 9.9e-10 | 1.0e+00 | 100 | Cspg5 Setd2 Pth1r Dclk3 Mlh1 Ccdc71 |
25 | 9 | 12682987 | 14081256 | 1 | 1 | 2.8e-07 | 2.2e-06 | 1.7e-02 | 75 | Med20 |
26 | 10 | 81874092 | 84687108 | 20 | 1 | 2.7e-08 | 8.6e-08 | 3.6e-01 | 97 | NA |
27 | 10 | 87823507 | 89221041 | 1 | 1 | 2.3e-07 | 3.2e-06 | 2.2e-01 | 93 | Prp2l1 |
28 | 10 | 92588108 | 96071622 | 16 | 5 | 1.8e-10 | 1.5e-10 | NaN | NaN | Wipi1 Arsg Abca8a Map2k6 Abca9 |
29 | 10 | 105128372 | 107195627 | 3 | 1 | 1.0e-07 | 1.9e-07 | 9.3e-89 | -1369 | NA |
30 | 11 | 2994207 | 4393389 | 1 | 1 | 1.5e-09 | 2.1e-06 | 8.7e-01 | 100 | NA |
31 | 12 | 27006 | 6860177 | 42 | 5 | 2.8e-22 | 7.6e-22 | 1.0e+00 | 100 | Pcp2 Snapc2 Stard13 Brca2 B3glct |
32 | 14 | 61859220 | 63251899 | 1 | 1 | 6.3e-09 | 3.8e-09 | 1.0e+00 | 100 | Pacrgl |
33 | 14 | 77172158 | 78568533 | 1 | 1 | 1.4e-07 | 2.9e-06 | 1.4e-01 | 90 | Prr14l |
34 | 18 | 25166673 | 27022191 | 10 | 5 | 1.5e-10 | 3.3e-10 | 1.0e+00 | 100 | Reep5 Fam13b Apc Cdc23 Epb41l4a |
35 | 20 | 3201 | 847737 | 3 | 3 | 2.6e-08 | 4.3e-08 | 0.0e+00 | -16307 | Clic2 Tmlhe NA |
36 | 20 | 883910 | 4846491 | 56 | 7 | 4.6e-10 | 3.2e-09 | 1.0e+00 | 100 | Abcf1 Mrps18b Atat1 RT1-N2 NA RT1-CE11 NA |
37 | 20 | 5885475 | 8780288 | 23 | 5 | 1.3e-09 | 4.1e-09 | 1.0e+00 | 100 | Slc26a8 Mapk14 RGD735065 Ccdc167 NA |
p0: physical position of the start of the locus. p1: physical position of the end of the locus. # joint models: number of models selected by step-wise conditional analysis.
chisq ratio: Average Chi2 statistic for the selected genes in the secondary trait, divided by the average statistic for all genes in the secondary trait. # genes+: Shared significant genes at Bonferroni correction. # genes++: Shared significant genes at transcriptome-wide significance. % genes++: Number of [++] genes as a percentage of primary trait’s total joint genes. corr: Correlation of effect sizes across the [+] genes.
tissue | modality | # hits | % hits/tests | avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 62 | 2.92 | 4.6 |
Adipose | alternative TSS | 22 | 1.36 | 4.0 |
Adipose | gene expression | 118 | 1.42 | 3.9 |
Adipose | isoform ratio | 58 | 2.05 | 4.3 |
Adipose | intron excision ratio | 43 | 1.47 | 3.8 |
Adipose | mRNA stability | 59 | 1.71 | 4.1 |
BLA | alternative polyA | 12 | 1.00 | 4.3 |
BLA | alternative TSS | 10 | 1.19 | 4.1 |
BLA | gene expression | 115 | 1.90 | 4.3 |
BLA | isoform ratio | 28 | 1.59 | 4.4 |
BLA | intron excision ratio | 68 | 2.28 | 4.5 |
BLA | mRNA stability | 49 | 2.42 | 4.5 |
Brain | alternative polyA | 28 | 1.40 | 4.2 |
Brain | alternative TSS | 30 | 1.75 | 4.4 |
Brain | gene expression | 152 | 1.68 | 4.1 |
Brain | isoform ratio | 60 | 1.90 | 4.2 |
Brain | intron excision ratio | 98 | 1.81 | 4.3 |
Brain | mRNA stability | 73 | 1.67 | 4.0 |
Eye | alternative polyA | 0 | 0.00 | 4.2 |
Eye | alternative TSS | 6 | 2.50 | 4.1 |
Eye | gene expression | 18 | 1.60 | 4.2 |
Eye | isoform ratio | 5 | 1.41 | 4.3 |
Eye | intron excision ratio | 13 | 2.12 | 4.8 |
Eye | mRNA stability | 3 | 1.29 | 4.3 |
IL | alternative polyA | 10 | 1.64 | 4.8 |
IL | alternative TSS | 3 | 1.04 | 4.4 |
IL | gene expression | 61 | 1.67 | 4.3 |
IL | isoform ratio | 18 | 2.28 | 4.7 |
IL | intron excision ratio | 12 | 1.24 | 4.4 |
IL | mRNA stability | 23 | 2.07 | 4.3 |
LHb | alternative polyA | 7 | 1.22 | 4.7 |
LHb | alternative TSS | 2 | 0.57 | 3.8 |
LHb | gene expression | 58 | 1.81 | 4.3 |
LHb | isoform ratio | 5 | 0.66 | 4.4 |
LHb | intron excision ratio | 9 | 0.87 | 4.5 |
LHb | mRNA stability | 24 | 2.32 | 4.5 |
Liver | alternative polyA | 30 | 2.00 | 4.3 |
Liver | alternative TSS | 20 | 1.32 | 4.0 |
Liver | gene expression | 102 | 1.42 | 4.0 |
Liver | isoform ratio | 40 | 1.67 | 4.3 |
Liver | intron excision ratio | 68 | 1.56 | 3.9 |
Liver | mRNA stability | 50 | 2.04 | 4.2 |
NAcc | alternative polyA | 11 | 2.11 | 5.2 |
NAcc | alternative TSS | 6 | 1.75 | 4.3 |
NAcc | gene expression | 54 | 1.64 | 4.2 |
NAcc | isoform ratio | 11 | 1.48 | 4.2 |
NAcc | intron excision ratio | 17 | 1.78 | 4.6 |
NAcc | mRNA stability | 19 | 1.76 | 4.3 |
NAcc2 | alternative polyA | 16 | 1.45 | 4.2 |
NAcc2 | alternative TSS | 14 | 1.91 | 4.3 |
NAcc2 | gene expression | 103 | 1.93 | 4.3 |
NAcc2 | isoform ratio | 25 | 1.62 | 4.4 |
NAcc2 | intron excision ratio | 47 | 1.78 | 4.3 |
NAcc2 | mRNA stability | 29 | 1.62 | 4.3 |
OFC | alternative polyA | 10 | 1.71 | 4.9 |
OFC | alternative TSS | 6 | 1.88 | 4.6 |
OFC | gene expression | 68 | 1.84 | 4.4 |
OFC | isoform ratio | 8 | 0.98 | 4.5 |
OFC | intron excision ratio | 18 | 1.79 | 4.8 |
OFC | mRNA stability | 22 | 2.04 | 4.7 |
PL | alternative polyA | 8 | 1.34 | 4.5 |
PL | alternative TSS | 2 | 0.65 | 4.2 |
PL | gene expression | 65 | 1.75 | 4.2 |
PL | isoform ratio | 15 | 1.72 | 4.3 |
PL | intron excision ratio | 25 | 2.40 | 4.7 |
PL | mRNA stability | 22 | 1.91 | 4.5 |
PL2 | alternative polyA | 20 | 1.59 | 4.5 |
PL2 | alternative TSS | 30 | 3.19 | 4.7 |
PL2 | gene expression | 118 | 1.85 | 4.3 |
PL2 | isoform ratio | 30 | 1.63 | 4.4 |
PL2 | intron excision ratio | 72 | 2.29 | 4.6 |
PL2 | mRNA stability | 48 | 1.97 | 4.4 |
avg chisq: Average Chi2 (squared Z-score) across all models in this panel for this trait.